Barrow, Hanley, Mewhinney & Strauss’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $352M | Sell |
|
|||||
|
2025
Q1 | $408M | Sell |
|
|||||
|
2024
Q4 | $371M | Sell |
|
|||||
|
2024
Q3 | $452M | Buy |
|
|||||
|
2024
Q2 | $288M | Buy |
|
|||||
|
2024
Q1 | $135M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $3.06M | Sell |
|
|||||
|
2021
Q4 | $3.52M | Hold |
|
|||||
|
2021
Q3 | $3.39M | Sell |
|
|||||
|
2021
Q2 | $3.79M | Sell |
|
|||||
|
2021
Q1 | $3.78M | Hold |
|
|||||
|
2020
Q4 | $3.71M | Sell |
|
|||||
|
2020
Q3 | $3.89M | Sell |
|
|||||
|
2020
Q2 | $5.07M | Sell |
|
|||||
|
2020
Q1 | $26.8M | Sell |
|
|||||
|
2019
Q4 | $54.4M | Sell |
|
|||||
|
2019
Q3 | $484M | Sell |
|
|||||
|
2019
Q2 | $580M | Sell |
|
|||||
|
2019
Q1 | $1,000M | Buy |
|
|||||
|
2018
Q4 | $975M | Buy |
|
|||||
|
2018
Q3 | $912M | Buy |
|
|||||
|
2018
Q2 | $779M | Sell |
|
|||||
|
2018
Q1 | $867M | Sell |
|
|||||
|
2017
Q4 | $962M | Sell |
|
|||||
|
2017
Q3 | $1.19B | Sell |
|
|||||
|
2017
Q2 | $1.21B | Sell |
|
|||||
|
2017
Q1 | $1.33B | Buy |
|
|||||
|
2016
Q4 | $1.19B | Sell |
|
|||||
|
2016
Q3 | $1.2B | Buy |
|
|||||
|
2016
Q2 | $1.18B | Sell |
|
|||||
|
2016
Q1 | $1.17B | Sell |
|
|||||
|
2015
Q4 | $1.26B | Buy |
|
|||||
|
2015
Q3 | $1.38B | Sell |
|
|||||
|
2015
Q2 | $1.48B | Sell |
|
|||||
|
2015
Q1 | $1.49B | Sell |
|
|||||
|
2014
Q4 | $1.4B | Buy |
|
|||||
|
2014
Q3 | $1.6B | Sell |
|
|||||
|
2014
Q2 | $1.52B | Buy |
|
|||||
|
2014
Q1 | $1.45B | Buy |
|
|||||
|
2013
Q4 | $1.21B | Buy |
|
|||||
|
2013
Q3 | $1.09B | Buy |
|
|||||
|
2013
Q2 | $268M | Buy |
|